Heart failure is a leading cause of death and disability. Unfortunately, this affects millions of individuals and their loved ...

Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure characterized by impaired cardiac filling. In a recent study, his group and ...

People who receive stem cell therapy within a week of their first heart attack have nearly a 60 per cent lower risk of ...

Heart failure (HF) is one of the leading causes of death and disability worldwide, affecting millions of people and placing ...

Cardiac complications in Duchenne muscular dystrophy (DMD) are the result of cardiac muscle involvement that accompanies the deterioration of skeletal muscle in the disease. The use of ...

Researchers have investigated the effect of increased cell temperature on the contractility of skeletal muscle and cardiac muscle by heating the muscle proteins using advanced microscopical techniques ...

Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk of arrhythmias following this procedure is ...

—Starting cardiac medications, using the proper timing and dosing, to optimize the efficacy of therapies and improve patient outcomes, is key to cardiac care for patients with Duchenne muscular ...

A June 9 Instagram post (direct link, archive link) shows excerpts from a document that makes claims about mRNA COVID-19 vaccines. "We conclude that the mRNA vacs dramatically increase inflammation on ...